Annual report
9265.TEDINET S100WKIB
Period2024-06-01 → 2025-05-31
Filed2025-08-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥64.5bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥61.6bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥58.2bn | 2022-06-01 → 2023-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥55.1bn | 2021-06-01 → 2022-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥70.1bn | 2020-06-01 → 2021-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥838m | 2024-06-01 → 2025-05-31 | Cons. | Operating income |
| Operating income | ¥967m | 2023-06-01 → 2024-05-31 | Cons. | Operating income |
| Ordinary income | ¥909m | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-06-01 → 2023-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2020-06-01 → 2021-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥943m | 2024-06-01 → 2025-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥871m | 2023-06-01 → 2024-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥616m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥219m | 2022-06-01 → 2023-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥696m | 2021-06-01 → 2022-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥678m | 2020-06-01 → 2021-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥614m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss |
| Net income | ¥577m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss |
| Total assets | ¥27.5bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥26.6bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥24.6bn | at 2023-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.1bn | at 2022-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.3bn | at 2021-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥18.6bn | at 2025-05-31 | Cons. | Liabilities |
| Total liabilities | ¥18.0bn | at 2024-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.0bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥8.6bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2023-05-31v | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-05-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥7.6bn | at 2021-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.7bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.3bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.7bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.3bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2023-05-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.7bn | at 2021-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥617m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥878m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.2bn | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥581m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥911m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥19m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥107m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥27m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥134m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥240m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥335m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥209m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥229m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥137m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥249.79 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥227.96 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.83 | 2022-06-01 → 2023-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.67 | 2021-06-01 → 2022-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥265.77 | 2020-06-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,640.22 | at 2025-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,429.08 | at 2024-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,097.34 | at 2023-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,126.18 | at 2022-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,969.03 | at 2021-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 32.6% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2023-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.2% | at 2021-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.0% | 2024-06-01 → 2025-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2023-06-01 → 2024-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2022-06-01 → 2023-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2021-06-01 → 2022-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2020-06-01 → 2021-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 613 | at 2025-05-31 | Cons. | Number of employees |
| Employees | 606 | at 2024-05-31 | Cons. | Number of employees |
| Employees | 570 | at 2023-05-31v | Cons. | Number of employees |
| Employees | 574 | at 2022-05-31v | Cons. | Number of employees |
| Employees | 553 | at 2021-05-31d | Cons. | Number of employees |
| Revenue | ¥1.4bn | 2024-06-01 → 2025-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥1.4bn | 2023-06-01 → 2024-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥498m | 2022-06-01 → 2023-05-31v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥792m | 2021-06-01 → 2022-05-31v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥854m | 2020-06-01 → 2021-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥729m | 2024-06-01 → 2025-05-31 | Standalone | Operating income |
| Operating income | ¥763m | 2023-06-01 → 2024-05-31 | Standalone | Operating income |
| Ordinary income | ¥728m | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥764m | 2023-06-01 → 2024-05-31 | Standalone | Ordinary income |
| Ordinary income | −¥16m | 2022-06-01 → 2023-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥227m | 2021-06-01 → 2022-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥347m | 2020-06-01 → 2021-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥728m | 2024-06-01 → 2025-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥764m | 2023-06-01 → 2024-05-31 | Standalone | Income before income taxes |
| Net income | ¥718m | 2024-06-01 → 2025-05-31 | Standalone | Profit loss |
| Net income | ¥767m | 2023-06-01 → 2024-05-31 | Standalone | Profit loss |
| Net income | −¥13m | 2022-06-01 → 2023-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥228m | 2021-06-01 → 2022-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥348m | 2020-06-01 → 2021-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.5bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥8.0bn | at 2024-05-31 | Standalone | Assets |
| Total assets | ¥6.3bn | at 2023-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥6.5bn | at 2022-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥6.4bn | at 2021-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2025-05-31 | Standalone | Liabilities |
| Total liabilities | ¥1.8bn | at 2024-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥6.8bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥6.3bn | at 2024-05-31 | Standalone | Net assets |
| Net assets / equity | ¥5.8bn | at 2023-05-31v | Standalone | Net assets |
| Net assets / equity | ¥6.0bn | at 2022-05-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥6.0bn | at 2021-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥732m | at 2025-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥312m | at 2024-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥291.15 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥301.31 | 2023-06-01 → 2024-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.29 | 2022-06-01 → 2023-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.32 | 2021-06-01 → 2022-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.46 | 2020-06-01 → 2021-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥75 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2023-06-01 → 2024-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥48 | 2022-06-01 → 2023-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥82 | 2021-06-01 → 2022-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-06-01 → 2021-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,741.18 | at 2025-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,521.27 | at 2024-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,272.88 | at 2023-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,360.07 | at 2022-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,360.75 | at 2021-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 79.2% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.2% | at 2024-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.2% | at 2023-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.4% | at 2022-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.8% | at 2021-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.0% | 2024-06-01 → 2025-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2023-06-01 → 2024-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -0.2% | 2022-06-01 → 2023-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2021-06-01 → 2022-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-06-01 → 2021-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,553,000 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2024-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2023-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2022-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2021-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 30 | at 2025-05-31 | Standalone | Number of employees |
| Employees | 29 | at 2024-05-31 | Standalone | Number of employees |
| Employees | 30 | at 2023-05-31v | Standalone | Number of employees |
| Employees | 27 | at 2022-05-31v | Standalone | Number of employees |
| Employees | 24 | at 2021-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2024-06-01 → 2025-05-31 | ¥37m |
| Reconciling Itemsreconciling | revenue | 2024-06-01 → 2025-05-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2024-06-01 → 2025-05-31 | −¥1.1bn |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥6m |
| Medical Equipment Manufacturing And Salesreportable segment | employees | at 2025-05-31 | 7 pure |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥219m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥219m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥0 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2024-06-01 → 2025-05-31 | −¥220m |
| Medical Equipment Salesreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥122m |
| Medical Equipment Salesreportable segment | employees | at 2025-05-31 | 561 pure |
| Medical Equipment Salesreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥64.2bn |
| Medical Equipment Salesreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥64.2bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥0 |
| Medical Equipment Salesreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥2.2bn |
| Medical Mallreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥14m |
| Medical Mallreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥72m |
| Medical Mallreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥72m |
| Medical Mallreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥5m |
| —segment total | depreciation | 2024-06-01 → 2025-05-31 | ¥143m |
| —segment total | revenue | 2024-06-01 → 2025-05-31 | ¥64.5bn |
| —segment total | revenue external | 2024-06-01 → 2025-05-31 | ¥64.5bn |
| —segment total | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥0 |
| —segment total | segment profit | 2024-06-01 → 2025-05-31 | ¥2.0bn |
| Reconciling Itemsreconciling | depreciation | 2023-06-01 → 2024-05-31 | ¥27m |
| Reconciling Itemsreconciling | revenue | 2023-06-01 → 2024-05-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-06-01 → 2024-05-31 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2024-05-31 | −¥1.2bn |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥2m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥267m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥267m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2023-06-01 → 2024-05-31 | ¥0 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2023-06-01 → 2024-05-31 | −¥1m |
| Medical Equipment Salesreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥138m |
| Medical Equipment Salesreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥61.2bn |
| Medical Equipment Salesreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥61.2bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2023-06-01 → 2024-05-31 | ¥0 |
| Medical Equipment Salesreportable segment | segment profit | 2023-06-01 → 2024-05-31 | ¥2.2bn |
| Medical Mallreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥16m |
| Medical Mallreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥68m |
| Medical Mallreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥68m |
| Medical Mallreportable segment | segment profit | 2023-06-01 → 2024-05-31 | ¥0 |
| —segment total | depreciation | 2023-06-01 → 2024-05-31 | ¥157m |
| —segment total | revenue | 2023-06-01 → 2024-05-31 | ¥61.6bn |
| —segment total | revenue external | 2023-06-01 → 2024-05-31 | ¥61.6bn |
| —segment total | revenue intersegment | 2023-06-01 → 2024-05-31 | ¥1m |
| —segment total | segment profit | 2023-06-01 → 2024-05-31 | ¥2.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,479
| Item | Context | Value | Unit |
|---|---|---|---|
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Shareholding by shareholder category (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)山下 尚登 | |
| Address major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)長崎県佐世保市 | |
| Name major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)株式会社ＳＢＩ証券 | |
| Address major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区六本木１丁目６番１号 | |
| Name major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)ヤマシタヘルスケアホールディングス社員持株会 | |
| Address major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)福岡県福岡市博多区下川端町２－１ | |
| Name major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)山下 弘高 | |
| Address major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)福岡県大野城市 | |
| Name major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)山下 耕一 | |
| Address major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)福岡県福岡市中央区 | |
| Name major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)株式会社十八親和銀行 | |
| Address major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)長崎県長崎市銅座町１－11 | |
| Name major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)小沼 滋紀 | |
| Address major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)千葉県野田市 | |
| Name major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)山下 浩 | |
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)長崎県佐世保市 | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)株式会社ＥＰＡＲＫ | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)東京都港区芝浦４丁目16－25 | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)内藤 征吾 | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)東京都中央区 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)ヤマシタヘルスケアホールディングス株式会社 | |
| Address of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)福岡県福岡市博多区下川端町２－１ | |
| Classes of shares etc (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of shareholders meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Disposals or holding of acquired treasury shares (text) | FilingDateInstant | Text · Plus | |
| Dividend policy (text) | FilingDateInstant | Text · Plus | |
| Date of resolution dividends of surplus | FilingDateInstant_Row1Member | 2025-08-28 | |
| Resolution dividends of surplus | FilingDateInstant_Row1Member | Original text (Japanese)定時株主総会決議（予定） | |
| Overview of corporate governance (text) | FilingDateInstant | Text · Plus | |
| Corporate governance company with audit and supervisory committee (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33393-000YamashitaNaotoMember | Original text (Japanese)代表取締役執行役員 社長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33393-000YamashitaNaotoMember | Original text (Japanese)山下 尚登 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33393-000YamashitaNaotoMember | 1955-01-24 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |